Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PK(Pharmacokinetic) Papyrus Covered Coronary Stent System

NCT: NCT06223633 · RECRUITING

NCT IDNCT06223633
StatusRECRUITING
Start Date2023-08-10
Completion2028-08
SponsorMethodist Health System (OTHER)
First posted
Last updated

Brief Summary

The PK Papyrus Covered Coronary Stent System is a coronary stent being used at Methodist Dallas Medical Center for patients with coronary perforations.

Frequently Asked Questions

What is PK(Pharmacokinetic) Papyrus Covered Coronary Stent System?

PK(Pharmacokinetic) Papyrus Covered Coronary Stent System is a clinical trial registered under NCT06223633. Current status: RECRUITING.

What is the status of NCT06223633?

The current status of NCT06223633 (PK(Pharmacokinetic) Papyrus Covered Coronary Stent System) is: RECRUITING.

When did PK(Pharmacokinetic) Papyrus Covered Coronary Stent System start?

PK(Pharmacokinetic) Papyrus Covered Coronary Stent System started on 2023-08-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑